Home › Targets › CD66

CD66 (1 companies · 3 programs)

Companies with an active program directed at CD66.

Telix Pharmaceuticals Ltd TLX

TLX66-Tx — Leukemia Phase 2
TLX66-Tx — Acute Myeloid Leukemia Phase 1
Scintimun — Osteomyelitis Approved